RGNX logo

REGENXBIO (RGNX) Total Liabilities

Annual Total Liabilities

$262.23 M
-$54.84 M-17.30%

31 December 2023

RGNX Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$217.70 M
-$3.41 M-1.54%

30 September 2024

RGNX Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGNX Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.3%-19.6%
3 y3 years-20.6%-35.8%
5 y5 years+650.0%+433.0%

RGNX Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-25.0%at low-37.7%at low
5 y5 years-25.0%+650.0%-37.7%+433.0%
alltimeall time-25.0%+5635.5%-37.7%+4661.6%

REGENXBIO Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$217.70 M(-1.5%)
June 2024
-
$221.11 M(-7.3%)
Mar 2024
-
$238.55 M(-9.0%)
Dec 2023
$262.23 M(-17.3%)
$262.23 M(-3.1%)
Sept 2023
-
$270.69 M(-2.1%)
June 2023
-
$276.60 M(-2.2%)
Mar 2023
-
$282.69 M(-10.8%)
Dec 2022
$317.07 M(-9.3%)
$317.07 M(-0.9%)
Sept 2022
-
$319.97 M(-0.9%)
June 2022
-
$322.93 M(-3.8%)
Mar 2022
-
$335.70 M(-4.0%)
Dec 2021
$349.61 M(+5.8%)
$349.61 M(+3.1%)
Sept 2021
-
$338.98 M(+3.0%)
June 2021
-
$329.16 M(+1.3%)
Mar 2021
-
$324.94 M(-1.7%)
Dec 2020
$330.41 M(+592.5%)
$330.41 M(+163.2%)
Sept 2020
-
$125.51 M(+141.9%)
June 2020
-
$51.88 M(+18.5%)
Mar 2020
-
$43.78 M(-8.2%)
Dec 2019
$47.71 M
$47.71 M(+16.8%)
DateAnnualQuarterly
Sept 2019
-
$40.84 M(+18.2%)
June 2019
-
$34.55 M(+8.0%)
Mar 2019
-
$31.98 M(-8.5%)
Dec 2018
$34.97 M(+123.5%)
$34.97 M(+67.1%)
Sept 2018
-
$20.93 M(+11.5%)
June 2018
-
$18.77 M(+5.0%)
Mar 2018
-
$17.88 M(+14.2%)
Dec 2017
$15.65 M(+42.3%)
$15.65 M(+7.1%)
Sept 2017
-
$14.60 M(+15.2%)
June 2017
-
$12.68 M(+12.9%)
Mar 2017
-
$11.23 M(+2.1%)
Dec 2016
$10.99 M(+140.5%)
$10.99 M(-30.2%)
Sept 2016
-
$15.75 M(+59.1%)
June 2016
-
$9.90 M(+55.1%)
Mar 2016
-
$6.38 M(+39.6%)
Dec 2015
$4.57 M(-50.2%)
$4.57 M(-17.0%)
Sept 2015
-
$5.51 M(-10.8%)
June 2015
-
$6.17 M(-32.8%)
Dec 2014
$9.19 M(+97.5%)
$9.19 M
Dec 2013
$4.65 M
-

FAQ

  • What is REGENXBIO annual total liabilities?
  • What is the all time high annual total liabilities for REGENXBIO?
  • What is REGENXBIO annual total liabilities year-on-year change?
  • What is REGENXBIO quarterly total liabilities?
  • What is the all time high quarterly total liabilities for REGENXBIO?
  • What is REGENXBIO quarterly total liabilities year-on-year change?

What is REGENXBIO annual total liabilities?

The current annual total liabilities of RGNX is $262.23 M

What is the all time high annual total liabilities for REGENXBIO?

REGENXBIO all-time high annual total liabilities is $349.61 M

What is REGENXBIO annual total liabilities year-on-year change?

Over the past year, RGNX annual total liabilities has changed by -$54.84 M (-17.30%)

What is REGENXBIO quarterly total liabilities?

The current quarterly total liabilities of RGNX is $217.70 M

What is the all time high quarterly total liabilities for REGENXBIO?

REGENXBIO all-time high quarterly total liabilities is $349.61 M

What is REGENXBIO quarterly total liabilities year-on-year change?

Over the past year, RGNX quarterly total liabilities has changed by -$52.99 M (-19.58%)